Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Long-acting injectable nanoparticle formulation for sustained release of anti-TNF-α antibody therapeutic in ulcerative colitis treatment

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.02.043Source: DataRank Database

Long-acting injectable nanoparticle formulation for sustained release of anti-TNF-α antibody therapeutic in ulcerative colitis treatment is a research paper published in Journal of Controlled Release (2025). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 10.71)OA: closedTopics (56)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Ling Li ORCID,Jiayuan Kong ORCID,Ya‐Qiu Long ORCID,Xiaoya Lu,Christopher J. Erb

Live enrichment

PubMed:39978474 OpenAlex:https://openalex.org/W4407848402

National Institutes of Health

Grant: R01DK135269

National Institutes of Health

Grant: R01NS134925

FWCI

10.71

Citation Percentile

1.0%

Citation Trend

2025

2026

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0168365925001567?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168365925001567?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jconrel.2025.02.043

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39978474

Fields of Study

Inflammatory Bowel DiseaseMicroscopic ColitisSystemic Lupus Erythematosus ResearchAnimalsColitis, UlcerativeDelayed-Action PreparationsTumor Necrosis Factor-alphaNanoparticlesAntibodies, MonoclonalDextran SulfateHyaluronic AcidDrug LiberationMiceFemaleHydrogelsMaleMice, Inbred C57BL

MeSH Terms

AnimalsAntibodies, MonoclonalColitis, UlcerativeDelayed-Action PreparationsFemaleHyaluronic AcidMaleMice, Inbred BALB CMice, Inbred C57BLTumor Necrosis Factor-alphaDextran SulfateHydrogelsMiceNanoparticlesDrug Liberation

Keywords

Ulcerative colitisIn vivoHyaluronic acidPharmacologyMedicineMonoclonal antibodyIn vitroTherapeutic effectAntibodyTumor necrosis factor alphaColitisChemistryImmunologyInternal medicineBiochemistryBiologyInflammatory Bowel Diseasesustained releaseLong-acting InjectableHyaluronic Acid HydrogelChronic ColitisFlash NanoprecipitationTnf-α AntibodyFlash Nanocomplexation

Sustainable Development Goals

SDG 0: Good health and well-being

Long-acting injectable nanoparticle formulation for sustained release of anti-TNF-α antibody therapeutic in ulcerative colitis treatment

FAIR Checklist

Authors (12)

Funding (2 grants)

Impact

Open Access

Topics